Autosomal dominant von willebrand disease type 2M

Acta Haematologica

Volumn 121, Issue 2-3, 2009, Pages 139-144

  Hermans, Cedric ^a   Batlle, Javier ^b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

Desmopressin response; Multimeric patterns; Phenotype; Platelet adhesion; Type 2M; Von Willebrand disease

Indexed keywords

COLLAGEN; DESMOPRESSIN; GLYCOPROTEIN IB ALPHA; RISTOCETIN; VON WILLEBRAND FACTOR;

AUTOSOMAL DOMINANT DISORDER; FAMILY HISTORY; GENOTYPE; HEMOSTASIS; HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; THROMBOCYTE ADHESION; THROMBOCYTE AGGLUTINATION; THROMBOCYTE AGGREGATION; VON WILLEBRAND DISEASE; BLEEDING TIME; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; DOMINANT GENE; DRUG EFFECT; GENETICS; MISSENSE MUTATION; MOLECULAR WEIGHT; NOMENCLATURE; POINT MUTATION; PROTEIN ELECTROPHORESIS; PROTEIN QUATERNARY STRUCTURE; PROTEIN TERTIARY STRUCTURE;

BLEEDING TIME; BLOOD PROTEIN ELECTROPHORESIS; COLLAGEN; GENES, DOMINANT; GENOTYPE; HUMANS; MODELS, MOLECULAR; MOLECULAR WEIGHT; MUTATION, MISSENSE; PHENOTYPE; PLATELET AGGREGATION; POINT MUTATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; TERMINOLOGY AS TOPIC; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 67649666847     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000214854     Document Type: Review

References (21)

1. Ruggeri ZM: The role of von Willebrand factor and fibrinogen in the initiation of platelet adhesion to thrombogenic surfaces. Thromb Haemost 1995;74:460-463.
2. Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, Ingerslev J, Lee CA, Lillicrap D, Mannucci PM, Mazurier C, Meyer D, Nichols WL, Nishino M, Peake IR, Rodeghiero F, Schneppenheim R, Ruggeri ZM, Srivastava A, Montgomery RR, Federici AB: Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006; 4: 2103-2114.
3. Meyer D, Fressinaud E, Hilbert L, Ribba AS, Lavergne JM, Mazurier C: Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function. Best Pract Res Clin Haematol 2001;14:349- 364.
4. Lillicrap D: Von Willebrand disease - phenotype versus genotype: deficiency versus disease. Thromb Res 2007; 120(suppl 1):S11- S16.
5. Ribba AS, Loisel I, Lavergne JM, Juhan-Vague I, Obert B, Cherel G, Meyer D, Girma JP: Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen. Thromb Haemost 2001; 86:848-854.
6. James PD, Notley C, Hegadorn C, Leggo J, Tuttle A, Tinlin S, Brown C, Andrews C, Labelle A, Chirinian Y, O'Brien L, Othman M, Rivard G, Rapson D, Hough C, Lillicrap D: The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study. Blood 2007;109:145-154.
7. Goudemand J, Schneppenheim R, Budde U, Ingerslev J, Habart D, Vorlova Z, Holmberg L, Lethagen S, Pasi J, Hill F, Hashemi SM, Baronciani L, Hallden C, Guilliatt A, Lester W, Peake I: Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM1VWD). Blood 2007;109:112-121.
8. Cumming A, Grundy P, Keeney S, Lester W, Enayat S, Guilliatt A, Bowen D, Pasi J, Keeling D, Hill F, Bolton-Maggs PH, Hay C, Collins P: An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease. Thromb Haemost 2006;96:630- 641.
9. Nitu-Whalley IC, Riddell A, Lee CA, Pasi KJ, Owens D, Enayat MS, Perkins SJ, Jenkins PV: Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modelling. Thromb Haemost 2000;84:998-1004.
10. Penas N, Perez-Rodriguez A, Torea JH, Loures E, Noya MS, Lopez-Fernandez MF, Batlle J: von Willebrand disease R1374C: type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of Spain (Galicia). Am J Hematol 2005;80:188- 196.
11. University of Sheffield: ISTH SSC VWF Database. http://www.vwf.group. shef.ac.uk/index.html
12. Hilbert L, Gaucher C, Mazurier C: Identification of two mutations (Arg611Cys and Arg611His) in the A1 loop of von Willebrand factor (vWF) responsible for type 2 von Willebrand disease with decreased platelet-dependent function of vWF. Blood 1995;86: 1010-1018.
13. Casonato A, Pontara E, Sartorello F, Bertomoro A, Durante C, Girolami A: Type 2M von Willebrand disease variant characterized by abnormal von Willebrand factor multimerization. J Lab Clin Med 2001;137: 70-76.
14. Lethagen S, Frick K, Isaksson C, Kristoffersson A-C, Holmberg L: Revised classification and treatment of von Willebrand disease. Thromb Haemost 1998;80:199-200.
15. Hoyer LW, Rizza CR, Tuddenham GD, Carta CA, Armitage H, Rotblat F: von Willebrand factor multimer patterns in von Willebrand 's disease. Br J Haematol 1983;55:493-507.
16. Schneppenheim R, Budde U, Ruggeri ZM: A molecular approach to the classification of von Willebrand disease (review). Best Pract Res Clin Haematol 2001;14:281-298.
17. Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van de Velde A, van Vliet H: Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Wil-lebrand disease. Clin Appl Thromb Hemost 2006;12:397-420.
18. Favaloro EJ: Collagen binding assay for von Willebrand factor (VWF:CBA): detection of von Willebrands disease (VWD), and discrimination of VWD subtypes, depends on col lagen source. Thromb Haemost 2000;83: 127-135.
19. Riddell AF, Jenkins PV, Nitu-Whalley IC, McCraw AH, Lee CA, Brown SA: Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay. Br J Haematol 2002;116: 187-192.
20. Federici AB, Mazurier C, Berntorp E, Lee CA, Goudemand J, Lethagen S, Nitu I, Ludwig G, Hilbert L, Mannucci PM: Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study. Blood 2004; 103:2032-2038.
21. Batlle J, Pérez-Rodríguez A, Franqueira MD, López-Fernández MF: Type 2M von Willebrand disease: a va riant of ty pe 2A? J Thromb Haemost 2008; 6: 388-390.